메뉴 건너뛰기




Volumn 119, Issue 7, 2012, Pages 771-778

Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients

Author keywords

A 42; Alzheimer's disease; Cerebrospinal fluid; SLAI; TMS

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; TAU PROTEIN;

EID: 84863430000     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-012-0780-4     Document Type: Article
Times cited : (34)

References (51)
  • 1
    • 52349099782 scopus 로고    scopus 로고
    • Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease
    • Aluise CD, Sowell RA, Butterfield DA (2008) Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease. Biochim Biophys Acta 1782(10):549-558
    • (2008) Biochim Biophys Acta , vol.1782 , Issue.10 , pp. 549-558
    • Aluise, C.D.1    Sowell, R.A.2    Butterfield, D.A.3
  • 2
    • 76649123574 scopus 로고    scopus 로고
    • CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease
    • Alzheimer's Disease Neuroimaging Initiative
    • Alzheimer's Disease Neuroimaging Initiative, Fjell AM, Walhovd KB, Fennema-Notestine C et al (2010) CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease. J Neurosci 30(6):2088-2101
    • (2010) J Neurosci , vol.30 , Issue.6 , pp. 2088-2101
    • Fjell, A.M.1    Walhovd, K.B.2    Fennema-Notestine, C.3
  • 3
    • 0036810329 scopus 로고    scopus 로고
    • Alzheimer's disease and the basal forebrain cholinergic system: Relations to beta-amyloid peptides, cognition, and treatment strategies
    • Auld DS, Kornecook TJ, Bastianetto S, Quirion R (2002) Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 68(3):209-245
    • (2002) Prog Neurobiol , vol.68 , Issue.3 , pp. 209-245
    • Auld, D.S.1    Kornecook, T.J.2    Bastianetto, S.3    Quirion, R.4
  • 4
    • 36549026988 scopus 로고    scopus 로고
    • Cortical plasticity in Alzheimer's disease in humans and rodents
    • Battaglia F, Wang HY, Ghilardi MF et al (2007) Cortical plasticity in Alzheimer's disease in humans and rodents. Biol Psychiatry 62(12):1405-1412
    • (2007) Biol Psychiatry , vol.62 , Issue.12 , pp. 1405-1412
    • Battaglia, F.1    Wang, H.Y.2    Ghilardi, M.F.3
  • 5
    • 0141738373 scopus 로고    scopus 로고
    • CSF markers for incipient Alzheimer's disease
    • Blennow K, Hampel H (2003) CSF markers for incipient Alzheimer's disease. Lancet Neurol 2:605-613
    • (2003) Lancet Neurol , vol.2 , pp. 605-613
    • Blennow, K.1    Hampel, H.2
  • 6
    • 65449157673 scopus 로고    scopus 로고
    • Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of Tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype
    • Blom ES, Giedraitis V, Zetterberg H et al (2009) Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of Tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype. Dement Geriatr Cogn Disord 27(5):458-464
    • (2009) Dement Geriatr Cogn Disord , vol.27 , Issue.5 , pp. 458-464
    • Blom, E.S.1    Giedraitis, V.2    Zetterberg, H.3
  • 7
    • 0031593593 scopus 로고    scopus 로고
    • Evolution of Alzheimer's disease related cortical lesions
    • Review
    • Braak H, Braak E, Bohl J, Bratzke H (1998) Evolution of Alzheimer's disease related cortical lesions. J Neural Transm Suppl 54:97-106 Review
    • (1998) J Neural Transm Suppl , vol.54 , pp. 97-106
    • Braak, H.1    Braak, E.2    Bohl, J.3    Bratzke, H.4
  • 8
    • 0025863618 scopus 로고
    • Neuropathological staging of Alzheimerrelated changes
    • Review
    • Braak H, Braak E (1991) Neuropathological staging of Alzheimerrelated changes. Acta Neuropathol 82(4):239-259 Review
    • (1991) Acta Neuropathol , vol.82 , Issue.4 , pp. 239-259
    • Braak, H.1    Braak, E.2
  • 9
    • 84863471364 scopus 로고    scopus 로고
    • Phosphorylated Tau predicts rate of cognitive decline in MCI subjects: A comparative CSF study
    • Buerger K, Ewers M, Andreasen N et al (2005) Phosphorylated Tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study. J Mol Biol 354(5):1021-1027
    • (2005) J Mol Biol , vol.354 , Issue.5 , pp. 1021-1027
    • Buerger, K.1    Ewers, M.2    Andreasen, N.3
  • 10
    • 10244255158 scopus 로고    scopus 로고
    • The Mental Deterioration Battery: Normative data, diagnostic reliability and qualitative analyses of cognitive impairment
    • The Group for the Standardization of the Mental Deterioration Battery
    • Carlesimo GA, Caltagirone C, Gainotti G (1996) The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 36:378-384
    • (1996) Eur Neurol , vol.36 , pp. 378-384
    • Carlesimo, G.A.1    Caltagirone, C.2    Gainotti, G.3
  • 12
    • 0037072309 scopus 로고    scopus 로고
    • Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation
    • Di Lazzaro V, Oliviero A, Tonali PA et al (2002) Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 13:392-397
    • (2002) Neurology , vol.13 , pp. 392-397
    • Di Lazzaro, V.1    Oliviero, A.2    Tonali, P.A.3
  • 14
    • 34548844202 scopus 로고    scopus 로고
    • Functional evaluation of cerebral cortex in dementia with Lewy bodies
    • Di Lazzaro V, Pilato F, Dileone M et al (2007) Functional evaluation of cerebral cortex in dementia with Lewy bodies. Neuroimage 37(2):422-429
    • (2007) Neuroimage , vol.37 , Issue.2 , pp. 422-429
    • Di Lazzaro, V.1    Pilato, F.2    Dileone, M.3
  • 15
    • 77957951112 scopus 로고    scopus 로고
    • Revising the definition of Alzheimer's disease: A new lexicon
    • Dubois B, Feldman HH, Jacova C et al (2010) Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol 9(11):1118-1127
    • (2010) Lancet Neurol , vol.9 , Issue.11 , pp. 1118-1127
    • Dubois, B.1    Feldman, H.H.2    Jacova, C.3
  • 16
    • 0030636350 scopus 로고    scopus 로고
    • Central cholinergic systems and cognition
    • Everitt BJ, Robbins TW (1997) Central cholinergic systems and cognition. Annu Rev Psychol 48:649-684
    • (1997) Annu Rev Psychol , vol.48 , pp. 649-684
    • Everitt, B.J.1    Robbins, T.W.2
  • 18
    • 41949104908 scopus 로고    scopus 로고
    • Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease
    • Geula C, Nagykery N, Nicholas A, Wu CK (2008) Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease. J Neuropathol Exp Neurol 67(4):309-318
    • (2008) J Neuropathol Exp Neurol , vol.67 , Issue.4 , pp. 309-318
    • Geula, C.1    Nagykery, N.2    Nicholas, A.3    Wu, C.K.4
  • 19
    • 33847662852 scopus 로고    scopus 로고
    • Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide
    • Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8(2):101-112
    • (2007) Nat Rev Mol Cell Biol , vol.8 , Issue.2 , pp. 101-112
    • Haass, C.1    Selkoe, D.J.2
  • 21
    • 0037135111 scopus 로고    scopus 로고
    • The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
    • Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297(5580):353-356
    • (2002) Science , vol.297 , Issue.5580 , pp. 353-356
    • Hardy, J.1    Selkoe, D.J.2
  • 22
    • 0343570105 scopus 로고    scopus 로고
    • Modulation of beta-amyloid precursor protein processing and Tau phosphorylation by acetylcholine receptors
    • Hellström-Lindahl E (2000) Modulation of beta-amyloid precursor protein processing and Tau phosphorylation by acetylcholine receptors. Eur J Pharmacol 393(1-3):255-263
    • (2000) Eur J Pharmacol , vol.393 , Issue.1-3 , pp. 255-263
    • Hellström-Lindahl, E.1
  • 23
    • 30744476741 scopus 로고    scopus 로고
    • Altered response to rTMS in patients with Alzheimer's disease
    • Inghilleri M, Conte A, Frasca V et al (2006) Altered response to rTMS in patients with Alzheimer's disease. Clin Neurophysiol 117(1):103-109
    • (2006) Clin Neurophysiol , vol.117 , Issue.1 , pp. 103-109
    • Inghilleri, M.1    Conte, A.2    Frasca, V.3
  • 24
    • 0034843660 scopus 로고    scopus 로고
    • Cellular mechanisms for amyloid beta-protein activation of rat cholinergic basal forebrain neurons
    • Jhamandas JH, Cho C, Jassar B, Harris K, MacTavish D, Easaw J (2001) Cellular mechanisms for amyloid beta-protein activation of rat cholinergic basal forebrain neurons. J Neurophysiol 86(3):1312-1320
    • (2001) J Neurophysiol , vol.86 , Issue.3 , pp. 1312-1320
    • Jhamandas, J.H.1    Cho, C.2    Jassar, B.3    Harris, K.4    MacTavish, D.5    Easaw, J.6
  • 25
    • 11344265672 scopus 로고    scopus 로고
    • Interactions between beta-amyloid and central cholinergic neurons: Implications for Alzheimer's disease
    • Kar S, Slowikowski SP, Westaway D, Mount HT (2004) Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J Psychiatry Neurosci 29(6):427-441
    • (2004) J Psychiatry Neurosci , vol.29 , Issue.6 , pp. 427-441
    • Kar, S.1    Slowikowski, S.P.2    Westaway, D.3    Mount, H.T.4
  • 26
    • 70350532722 scopus 로고    scopus 로고
    • CSF biomarkers predict rate of cognitive decline in Alzheimer disease
    • Kester MI, van der Vlies AE, Blankenstein MA et al (2009) CSF biomarkers predict rate of cognitive decline in Alzheimer disease. Neurology 73(17):1353-1358
    • (2009) Neurology , vol.73 , Issue.17 , pp. 1353-1358
    • Kester, M.I.1    Van Der Vlies, A.E.2    Blankenstein, M.A.3
  • 27
    • 79952311625 scopus 로고    scopus 로고
    • Altered dopamine modulation of LTD-like plasticity in Alzheimer's disease patients
    • Koch G, Esposito Z, CodecàC et al (2011a) Altered dopamine modulation of LTD-like plasticity in Alzheimer's disease patients. Clin Neurophysiol 122(4):703-707
    • (2011) Clin Neurophysiol , vol.122 , Issue.4 , pp. 703-707
    • Koch, G.1    Esposito, Z.2    Codecà, C.3
  • 28
    • 80052869455 scopus 로고    scopus 로고
    • CSF Tau levels influence cortical plasticity in Alzheimer's disease patients
    • Koch G, Esposito Z, Kusayanagi H et al (2011b) CSF Tau levels influence cortical plasticity in Alzheimer's disease patients. J Alzheimers Dis 26(1):181-186
    • (2011) J Alzheimers Dis , vol.26 , Issue.1 , pp. 181-186
    • Koch, G.1    Esposito, Z.2    Kusayanagi, H.3
  • 30
    • 68949191029 scopus 로고    scopus 로고
    • Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients
    • Martorana A, Mori F, Esposito Z et al (2009) Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients. Neuropsychopharmacology 34(10):2323-2328
    • (2009) Neuropsychopharmacology , vol.34 , Issue.10 , pp. 2323-2328
    • Martorana, A.1    Mori, F.2    Esposito, Z.3
  • 31
    • 77954369899 scopus 로고    scopus 로고
    • Beyond the cholinergic hypothesis: Do current drugs work in Alzheimer's disease?
    • Martorana A, Esposito Z, Koch G (2010) Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease? CNS Neurosci Ther 16(4):235-245
    • (2010) CNS Neurosci Ther , vol.16 , Issue.4 , pp. 235-245
    • Martorana, A.1    Esposito, Z.2    Koch, G.3
  • 32
    • 67651204382 scopus 로고    scopus 로고
    • CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
    • Mattsson N, Zetterberg H, Hansson O et al (2009) CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 302(4):385-393
    • (2009) JAMA , vol.302 , Issue.4 , pp. 385-393
    • Mattsson, N.1    Zetterberg, H.2    Hansson, O.3
  • 33
    • 79960764322 scopus 로고    scopus 로고
    • The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
    • Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S et al (2011) The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement 7(4):386.e6-395.e6
    • (2011) Alzheimers Dement , vol.7 , Issue.4
    • Mattsson, N.1    Andreasson, U.2    Persson, S.3    Arai, H.4    Batish, S.D.5    Bernardini, S.6
  • 35
    • 79960105632 scopus 로고    scopus 로고
    • Motor cortex hyperexcitability in subcortical ischemic vascular dementia
    • doi:10.1016/j.archger.2010.07.004
    • Pennisi G, Ferri R, Alagona G et al (2010) Motor cortex hyperexcitability in subcortical ischemic vascular dementia. Arch Gerontol Geriatr. doi:10.1016/j.archger.2010.07.004
    • (2010) Arch Gerontol Geriatr
    • Pennisi, G.1    Ferri, R.2    Alagona, G.3
  • 36
    • 67651204380 scopus 로고    scopus 로고
    • Use of Alzheimer disease biomarkers: Potentially yes for clinical trials but not yet for clinical practice
    • Petersen RC, Trojanowski JQ (2009) Use of Alzheimer disease biomarkers: potentially yes for clinical trials but not yet for clinical practice. JAMA 302(4):436-437
    • (2009) JAMA , vol.302 , Issue.4 , pp. 436-437
    • Petersen, R.C.1    Trojanowski, J.Q.2
  • 37
    • 30644475475 scopus 로고    scopus 로고
    • Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses
    • Roselli F, Tirard M, Lu J et al (2005) Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. J Neurosci 25(48):11061-11070
    • (2005) J Neurosci , vol.25 , Issue.48 , pp. 11061-11070
    • Roselli, F.1    Tirard, M.2    Lu, J.3
  • 38
    • 0027932909 scopus 로고
    • Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: Basic principles and procedures for routine clinical application. Report of an IFCN committee
    • Rossini PM, Barker AT, Berardelli A et al (1994) Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 91:79-92
    • (1994) Electroencephalogr Clin Neurophysiol , vol.91 , pp. 79-92
    • Rossini, P.M.1    Barker, A.T.2    Berardelli, A.3
  • 40
    • 34249718860 scopus 로고    scopus 로고
    • Short latency afferent inhibition is not impaired in mild cognitive impairment
    • Sakuma K, Murakami T, Nakashima K (2007) Short latency afferent inhibition is not impaired in mild cognitive impairment. Clin Neurophysiol 118(7):1460-1463
    • (2007) Clin Neurophysiol , vol.118 , Issue.7 , pp. 1460-1463
    • Sakuma, K.1    Murakami, T.2    Nakashima, K.3
  • 41
    • 77952541026 scopus 로고    scopus 로고
    • Abeta1-42 detection in CSF of Alzheimer's disease is influenced by temperature: Indication of reversible Abeta1-42 aggregation?
    • Sancesario GM, Esposito Z, Nuccetelli M et al (2010) Abeta1-42 detection in CSF of Alzheimer's disease is influenced by temperature: indication of reversible Abeta1-42 aggregation? Exp Neurol 223(2):371-376
    • (2010) Exp Neurol , vol.223 , Issue.2 , pp. 371-376
    • Sancesario, G.M.1    Esposito, Z.2    Nuccetelli, M.3
  • 42
    • 0031738101 scopus 로고    scopus 로고
    • Severing of F-actin by the amino-terminal half of gelsolin suggests internal cooperativity in gelsolin
    • Selden LA, Kinosian HJ, Newman J et al (1998) Severing of F-actin by the amino-terminal half of gelsolin suggests internal cooperativity in gelsolin. Biophys J 75:3092-3100
    • (1998) Biophys J , vol.75 , pp. 3092-3100
    • Selden, L.A.1    Kinosian, H.J.2    Newman, J.3
  • 43
    • 49149124343 scopus 로고    scopus 로고
    • Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
    • Shankar GM, Li S, Mehta TH et al (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14(8):837-842
    • (2008) Nat Med , vol.14 , Issue.8 , pp. 837-842
    • Shankar, G.M.1    Li, S.2    Mehta, T.H.3
  • 44
    • 33750445930 scopus 로고    scopus 로고
    • The significance of the cholinergic system in the brain during aging and in Alzheimer's disease
    • Schliebs R, Arendt T (2006) The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm 113(11):1625-1644
    • (2006) J Neural Transm , vol.113 , Issue.11 , pp. 1625-1644
    • Schliebs, R.1    Arendt, T.2
  • 46
    • 62449262536 scopus 로고    scopus 로고
    • Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain
    • Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, PirttiläT (2009) Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 66(3):382-389
    • (2009) Arch Neurol , vol.66 , Issue.3 , pp. 382-389
    • Tapiola, T.1    Alafuzoff, I.2    Herukka, S.K.3    Parkkinen, L.4    Hartikainen, P.5    Pirttilät, S.H.6
  • 47
    • 0037172826 scopus 로고    scopus 로고
    • Phases of A betadeposition in the human brain and its relevance for the development of AD
    • Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of A betadeposition in the human brain and its relevance for the development of AD. Neurology 58(12):1791-1800
    • (2002) Neurology , vol.58 , Issue.12 , pp. 1791-1800
    • Thal, D.R.1    Rüb, U.2    Orantes, M.3    Braak, H.4
  • 48
    • 77952351441 scopus 로고    scopus 로고
    • G protein-coupled receptors, cholinergic dysfunction, and Abeta toxicity in Alzheimer's disease
    • Review
    • Thathiah A, De Strooper B (2009) G protein-coupled receptors, cholinergic dysfunction, and Abeta toxicity in Alzheimer's disease. Sci Signal 2(93):re8 Review
    • (2009) Sci Signal , vol.2 , Issue.93
    • Thathiah, A.1    De Strooper, B.2
  • 49
    • 0034161758 scopus 로고    scopus 로고
    • Short latency inhibition of human hand motor cortex by somatosensory input from the hand
    • Tokimura H, Di Lazzaro V, Tokimura Y et al (2000) Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol (Lond) 523:503-513
    • (2000) J Physiol (Lond) , vol.523 , pp. 503-513
    • Tokimura, H.1    Di Lazzaro, V.2    Tokimura, Y.3
  • 51
    • 0032933137 scopus 로고    scopus 로고
    • Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia
    • Varma AR, Snowden JS, Lloyd JJ, Talbot PR, Mann DM, Neary D (1999) Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 66(2):184-188
    • (1999) J Neurol Neurosurg Psychiatry , vol.66 , Issue.2 , pp. 184-188
    • Varma, A.R.1    Snowden, J.S.2    Lloyd, J.J.3    Talbot, P.R.4    Mann, D.M.5    Neary, D.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.